Molecular Therapy — Nucleic Acids

84.1k citations
2.7k papers · · active since 1950

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • RNA Interference and Gene Delivery
    • Circular RNAs in diseases
    • Advanced biosensing and bioanalysis techniques
    • RNA modifications and cancer
    • CRISPR and Genetic Engineering
    • Extracellular vesicles in disease

Papers in

    • MicroRNA in disease regulation 585
    • Cancer-related molecular mechanisms research 483
    • RNA Interference and Gene Delivery 694
    • CRISPR and Genetic Engineering 424
    • Circular RNAs in diseases 379
    • Advanced biosensing and bioanalysis techniques 367
    • RNA modifications and cancer 313
    • RNA Research and Splicing 261

Molecular Therapy — Nucleic Acids

2.6k papers receiving 83.0k citations

Peers

Molecular Therapy — Nucleic Acids
Comparison fields: 5 of 210
  • Cancer Research 25.3k
  • Molecular Biology 61.6k
  • Business and International Management 714
  • Aging 550
  • Immunology 6.1k
Replace RNA Biology with:
RNA Biology United States
ACS Chemical Biology United States
Signal Transduction and Targeted Therapy China
Stem Cell Reports United States
EMBO Molecular Medicine United States
EBioMedicine United States
Cell Research China
Experimental & Molecular Medicine South Korea
Molecular Biotechnology China
Bioscience Reports China
Molecular Therapy — Nucleic Acids relative to RNA Biology United States RNA Biology's profile →
Citations per field
00.5×1.5×2.1×
RNA Biology · 1×
Citations per year

Countries where authors publish in Molecular Therapy — Nucleic Acids

Since Specialization
Citations

This map shows the geographic impact of research published in Molecular Therapy — Nucleic Acids. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Molecular Therapy — Nucleic Acids with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molecular Therapy — Nucleic Acids more than expected).

Fields of papers published in Molecular Therapy — Nucleic Acids

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Molecular Therapy — Nucleic Acids. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Molecular Therapy — Nucleic Acids.

About Molecular Therapy — Nucleic Acids

The 2.7k papers published in Molecular Therapy — Nucleic Acids in the last decades have received a total of 84.1k indexed citations . Papers published in Molecular Therapy — Nucleic Acids usually cover Cancer Research (912 papers), Molecular Biology (2.2k papers), Aging (24 papers), Genetics (359 papers) and Immunology (246 papers) specifically the topics of RNA Interference and Gene Delivery (694 papers), MicroRNA in disease regulation (585 papers), Cancer-related molecular mechanisms research (483 papers), CRISPR and Genetic Engineering (424 papers), Circular RNAs in diseases (379 papers), Advanced biosensing and bioanalysis techniques (367 papers), RNA modifications and cancer (313 papers) and RNA Research and Splicing (261 papers). The most active scholars publishing in Molecular Therapy — Nucleic Acids are Yuanyu Huang, Wei Chen, Yu Zhang, Jenny K.W. Lam, Michael Y.T. Chow, Susan W.S. Leung, Xiaogang Wang, Kuo‐Chen Chou, Shihua Yang and Louis Y. Tee.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact